Profluentbio is building protein foundation models for AI-designed therapeutics
nathanbenaich · x · 2026-07-29
Nathan Benaich highlights Profluentbio’s work on foundation models for proteins, framed around gene editing and future disease correction.
- The company is building protein foundation models.
- The scope goes beyond gene editing.
- The thesis is that AI-designed molecules will eventually help correct genetic diseases from scratch.
More from Companies & People
- Inside OpenAI’s push to redesign software development for the agent era — danshipper · 2026-07-29
- Open-source CLI agent goes public as more business-agent startups emerge — jasonkneen · 2026-07-29
- Sakana AI recruits for its Applied Defense team after a 150-person Tokyo expansion — garrytan · 2026-07-29
- Terra Turbo HyperCat says its stack now runs end to end on open-source models — max_paperclips · 2026-07-29
- Sarvam AI announces Epoch 2026, its flagship AI conference in India — itsOmSarraf_ · 2026-07-29
- AI consulting pitch says companies should keep the harness in-house, not hand off strategy — alex_verem · 2026-07-29